Contract Manufactured Liposomal Products
Controlled development, scale-up and manufacture of liposomal formulations, designed to minimise variability and support reproducible batch performance.
Specialist Manufacture of Advanced Liposomal Systems
GMPriority Pharma provides contract manufacturing for partners requiring controlled liposomal production within GMP-aligned environments.
Our model integrates formulation, process development and manufacturing from the outset, aligning particle size distribution, dispersion behaviour and processing conditions to support reproducible commercial output.
Rather than separating development from manufacture, programmes are structured to minimise scale-up variability and reduce risk during transfer to production.
From formulation to manufacturable system
Liposomal systems require control over multiple interdependent variables, including:
- Lipid composition and phase behaviour
- Particle size distribution and polydispersity (PDI)
- Dispersion stability under storage and handling conditions
- Processing parameters such as temperature, energy input and mixing
GMPriority Pharma manufactures liposomal systems in-house using defined production protocols designed to support consistency across batches.
This approach is intended to minimise process variability and support reproducible manufacturing performance.
A structured approach to contract manufacturing
GMPriority Pharma delivers contract manufacturing programmes through a defined integrated model spanning development, scale-up and commercial production.
Rather than separating formulation and manufacture, our approach ensures systems are designed, evaluated and produced within controlled operational frameworks from the outset.
- Formulation assessment and optimisation
- Process parameter definition (e.g. temperature, mixing, energy input)
- Scale-up under real manufacturing constraints
- Pilot batch production
- Commercial manufacturing and ongoing supply
Each stage is designed to minimise variability and support reproducible manufacturing outcomes.
From Development to Repeatable Manufacture
Successful liposomal products depend not only on formulation design, but on how those systems are translated into controlled manufacturing processes.
GMPriority Pharma works with partners to define formulations within real production constraints from the outset, supporting smoother transfer into commercial manufacture.
Development programmes are structured to:
- Evaluating formulation behaviour under real processing conditions
- Identifying scale-dependent constraints early
- Defining parameters aligned with manufacturing equipment
This approach is designed to support reproducible manufacturing performance and reliable long-term supply.
Contract Manufacturing Capabilities
- Liposomal encapsulation of partner formulations
- Liquid and dry-format manufacturing
- Process-defined scale-up and batch production
- Integration with partner supply chains
- Ongoing manufacturing and supply support
Designed for scale from the outset → Structured, repeatable production
Why Contract Manufacture?
Contract manufacturing is suited to:
- Brands with proprietary formulations requiring specialist liposomal production
- Formulators developing lipid-based delivery systems
- Ingredient companies developing advanced encapsulated formats
- Organisations requiring controlled, reproducible manufacturing environments
- Companies scaling from pilot to commercial production
Built for Scale & Reproducibility
Launch your product with confidence
GMPriority Pharma’s white label programmes provide a structured, controlled route to market, combining delivery science, manufacturing discipline and commercial readiness.
Finished products are developed with commercial manufacture in mind from the outset.
GMPriority Pharma focuses on formulation robustness, process transfer and batch-to-batch consistency, delivering products which can be manufactured reliably as volumes grow.
Scale-up is approached as a controlled extension of development logic, not as a reformulation exercise.
We support:
- Defined batch parameters
- Equipment compatibility
- Process documentation
- Reproducibility across production cycles.
This is particularly important for partners operating within regulated or quality-sensitive markets.
How We Engage
Our objective is to establish controlled, repeatable liposomal manufacturing programmes aligned with partner requirements and regulatory frameworks.
Engagement typically begins with:
Technical review of formulation requirements
Assessment of compatibility with liposomal processing
Definition of critical process parameters
Establishment of a controlled manufacturing and quality framework
Contact us
Bring your formulation to commercial scale.
GMPriority Pharma provides the structure, control and manufacturing capability required to translate liposomal formulations into reliable commercial products.
